Investors / Alzheimer's Drug Discovery Foundation Diagnostics Accelerator
Alzheimer's Drug Discovery Foundation Diagnostics Accelerator
Alzheimer's Drug Discovery Foundation Diagnostics Accelerator is a family office based in the United States. Alzheimer's Drug Discovery Foundation Diagnostics Accelerator has backed 1 Canadian AI company in the Index, joining 1 tracked round. The most recent was RetiSpec's US$10M Series A in July 2024. Alzheimer's Drug Discovery Foundation Diagnostics Accelerator most often invests alongside Centre for Aging + Brain Health Innovation, Discovery Capital (University of Minnesota) and Eli Lilly and Company.
Family Office based in US. 1 Canadian AI company in the Index, 1 tracked round.
- Type
- Family Office
- HQ country
- US
- Companies
- 1
- Tracked rounds
- 1
- Led
- 0
- First tracked deal
- RetiSpec, Jul 2024
- Latest tracked deal
- RetiSpec, Jul 2024
Portfolio
| Company | Rounds joined (date, round size) | Company's total raised | Role |
|---|---|---|---|
| RetiSpec | Series A · Jul 2024 · US$10M round | US$10M | — |
A round's size is the whole round as announced, not this investor's cheque.
Frequent co-investors
Centre for Aging + Brain Health Innovation (1 shared round), Discovery Capital (University of Minnesota) (1 shared round), Eli Lilly and Company (1 shared round), Gentex Corporation (1 shared round), iGan Partners (1 shared round), Ontario Brain Institute (1 shared round), Topcon Healthcare (1 shared round), Verge HealthTech Fund (1 shared round)
Data as of November 10, 2026.